Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    

SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ALLERGAN, INC.
06/07 Mylan defends chairman to ISS ahead of June 22 investor vote
06/07 ALLERGAN : to Present New Data on Chronic Migraine at the American Headache Soci..
06/05 FEATURED COMPANY NEWS - MYLAN LAUNCH : Generic Reclast® Injection and Generic Az..
05/31 ALLERGAN : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 201..
05/26 ALLERGAN PLC : Entry into a Material Definitive Agreement, Other Events, Financi..
05/25 ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
05/24 ALLERGAN : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch R..
05/23 ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
05/18 HEALTH CANADA APPROVES ALLERGAN PLC : AGN) IBS Drug Viberzi
05/16 ALLERGAN : Eyepowerment™ Campaign Releases Survey Revealing the Importance..
05/16 ALLERGAN : VIBERZI™ Now Approved in Canada for patients with irritable bow..
05/16 CARL ICAHN : Icahn takes new 19.8 million share stake in Conduent in first quart..
05/13 High-profile Snap stakeholders revealed in filings
05/13 High-profile Snap stakeholders revealed in filings
05/11 ALLERGAN, INC. : Today's Research Reports on Stocks to Watch: Allergan and Celge..
05/10 ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
05/09 ALLERGAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
05/09 Sanofi pegs U.S. drug price rises to below healthcare inflation
05/09 ALLERGAN PLC (NYSE : AGN) reported earnings of $3.35 per share beating Walls Str..
05/09 ALLERGAN PLC (NYSE : AGN) Files An 8-K Results of Operations and Financial Condi..
05/09 ALLERGAN PLC : Results of Operations and Financial Condition, Financial Statemen..
05/09 ALLERGAN : tops Street 1Q forecasts, deal fuels guidance hike
05/05 ALLERGAN PLC (NYSE : AGN) Files An 8-K Submission of Matters to a Vote of Securi..
05/05 ALLERGAN PLC : Submission of Matters to a Vote of Security Holders (form 8-K)
05/04 ALLERGAN : to Present New Data at the 2017 American College of Obstetricians and..
04/29 ALLERGAN : Successfully Completes ZELTIQ Aesthetics Acquisition
04/27 NOVARTIS : Allergan Expands Leading Research & Development NASH Program with Nov..
04/26 ALLERGAN : Granted Marketing Authorization by the FDA for TrueTear, the First In..
04/19 ALLERGAN : Novartis expands development programs for NASH through clinical colla..
04/18 ALLERGAN PLC (NYSE : AGN) Files An 8-K Other Events
04/18 ALLERGAN PLC : Other Events (form 8-K)
04/14 ALLERGAN : Exclusive New Interview Released with Allergan Global Regulatory Affa..
04/13 ALLERGAN : and Ironwood Launch Campaign Designed to Empower the Nearly 64 Millio..
04/12 ALLERGAN : New Interview Released with Allergan Global Regulatory Affairs Direct..
04/12 ALLERGAN PLC ORDINARY SHARES’ : AGN) Initiative Creating Awareness to Peo..
04/12 ALLERGAN : Introducing Juvederm Vollure® at The Choe Center
04/12 Just Three of World's Top 28 Pharmaceutical Corporations Agree to Match Pledg..
04/11 ALLERGAN : Launches Frames of Mind, Encouraging People Living with Migraine to S..
04/08 ALLERGAN : After iffy phase 2, Allergan plows forward with phase 3 Botox depress..
04/07 ALLERGAN : Teams Up With Media Mogul Wendy Williams to Debut the Patient Empower..
04/07 ALLERGAN : acquires Zeltiq
04/07 ALLERGAN : To Test Botox For Depression Despite Mixed Results
04/06 IMPAX LABORATORIES : Board of Directors Appoints Paul M. Bisaro President and CE..
04/05 ALLERGAN : Center for Facial Rejuvenation's Cindy Wilson, NP Chosen as Official ..
04/05 ALLERGAN : exec Sanjiv Patel becomes new CEO at upstart Relay
04/02 ALLERGAN : Dr. Rubinstein Receives Allergan "Top 500" Award
03/30 ALLERGAN : FDA Approves Juvéderm Vollure XC for Laugh Lines, Notes Dr. F. Victor..
03/29 ALLERGAN : Dr. Justin Harper Selected for Allergans Facial Aesthetics National A..
03/29 ALLERGAN : Paratek hit late-stage acne goals, prep for sarecycline NDA
03/28 ALLERGAN, INC. : Blog Coverage Allergan and Paratek's Acne Drug Reported Positiv..
03/28 ALLERGAN : Paratek Announce Positive Results from Two Phase 3 Trials for Moderat..
03/28 ALLERGAN : Dr. Justin Harper Selected for Allergan's Facial Aesthetics National ..
03/27 ALLERGAN : and Paratek Show Positive Results For Acne Treatment
03/27 PARATEK PHARMACEUTICALS, INC. (NASDA : PRTK) Files An 8-K Regulation FD Disclosu..
03/27 ALLERGAN : What Are Inversion Deals?
03/24 GLOBAL GLAUCOMA THERAPEUTICS MARKET : Allergan, Merck, Novartis, Pfizer, Santen..
03/24 GLOBAL GASTROINTESTINAL DRUGS MARKET : Abbott Laboratories, Allergan, AstraZenec..
03/22 Global Inhalation & Nasal Spray Generic Drugs Market- Teva, Allergan PLC, Cip..
03/22 ALLERGAN : Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Oph..
03/20 ALLERGAN : JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Fac..
03/17 ALLERGAN : Prevent Blindness and Allergan Work Together Through See America to P..
03/17 ALLERGAN : Editas partner on CRISPR tech in eye diseases
03/17 ALLERGAN : Lupin in fast lane with 5 launches in 15 days
03/16 ALLERGAN : Prevent Blindness and Allergan Work Together Through 'See America' to..
03/16 ALLERGAN : Dr. Anil Shah MD, FACS Offers Juvederm Volbella for Lip Fullness And ..
03/16 ALLERGAN : celebrates commitment to KSA with new entity inaugural
03/15 ALLERGAN : Dr. Anil Shah MD, FACS Offers Juvederm Volbella® for Lip Fullness And..
03/15 EDITAS MEDICINE,INC. (NASDAQ : EDIT) Files An 8-K Entry into a Material Definiti..
03/15 Heptares adds Daiichi pain pact to string of R&D deals
03/15 ALLERGAN : Blindness treatment key to deal
03/14 ALLERGAN : Common explains why he's fighting against a blindness epidemic most p..
03/14 ALLERGAN : New Survey Reveals Impact Of Double Chin On Self-Perception And Behav..
03/14 CISCO SYSTEMS, INC. ADDS ALLERGAN CE : Csco)
03/13 FOOD AND DRUG ADMINISTRATION ACCEPTS : AGN) Vraylar For Review As A Supplemental..
03/11 ALLERGAN : Saudi LLC celebrates expansion and commitment to KSA
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
David Nakasone Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.0
JOHNSON & JOHNSON18.42%367 520
NOVARTIS12.96%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER5.20%203 487
MERCK AND COMPANY12.38%180 958
More Results